Bone Strength After Menopause: Beyond Calcium to Minerals and the Collagen Framework

Bone is not a block of chalk

Picture bone and most people imagine something like chalk, a hard white mineral that gets thinner with age. That picture is the reason so many women pour in calcium and still lose bone.

Bone is closer to reinforced concrete. There is a flexible framework of protein, mostly type I collagen, laid down first. Then calcium and other minerals harden onto that framework to make it stiff and strong. The collagen gives bone the ability to bend a little under load instead of shattering. The mineral gives it the hardness to bear weight.

Take away the framework and calcium has nothing well organized to bind to. This is why bone strength is never just a calcium number. Two women can have similar mineral density and very different fracture risk, because one has a healthier collagen framework holding it all together.

What menopause does to the framework, not just the mineral

The calcium conversation focuses on the mineral because that is what a DXA scan measures. But menopause hits the framework too.

Estrogen kept the whole renovation running, both the mineral side and the collagen side. When it falls, the body makes less new collagen framework while continuing to break down the old, and the trace minerals that help weave and cross-link that framework are drawn down too. So a woman after menopause is losing structure on several fronts at once, and adding calcium addresses only one of them.

That is the honest limit of the calcium-only approach. It is not useless. It is incomplete, because it feeds the mineral while leaving the framework and the rebuild signal unaddressed.

Where shilajit works on the fuller picture

Shilajit enters here precisely because it is not a single isolated mineral. It is a whole-food mineral resin from the Altai mountains, carrying fulvic acid and a spread of trace minerals in a form the body recognizes, and its research reaches both the framework and the signal.

Start with the framework. In human research, Das and colleagues in 2016 gave shilajit to people and biopsied muscle tissue, and found a cluster of connective-tissue genes switched on, with the body's own collagen genes rising several fold. In a separate 2019 human study in women, Das found shilajit switched on the skin's collagen and blood-vessel genes. These are human results showing shilajit prompting the body to build its own collagen, which is the framework bone strength depends on.

The human bone trial ties it together

The framework research is compelling on its own, but the bone trial is where it lands on actual bone density.

Published in 2022 in Phytomedicine by Pingali and Nutalapati, it ran 48 weeks in 60 postmenopausal women with low bone mass, randomized, double blind, placebo controlled. The placebo group kept losing bone. Both shilajit groups, 250 mg and 500 mg a day, preserved and increased their density, and every woman who took it reversed her osteopenia.

There is a second piece of human evidence worth adding here. A 2020 double-blind randomized controlled trial in 160 people (Sadeghi and colleagues) found that oral shilajit, known regionally as momiai, cut the average tibial-fracture healing time to about 129 days versus 153 days on placebo, roughly 24 days faster https://pubmed.ncbi.nlm.nih.gov/32310691/. That is human evidence of shilajit actively supporting bone rebuilding, not just slowing loss.

The blood markers showed why. CTX-1, the marker of bone breakdown, fell by about 22 percent in the higher dose group. The protective signal OPG rose by about 57 percent, and the whole RANKL to OPG ratio, which governs how fast bone is dismantled, dropped by about 42 percent. The body was told to stop pulling bone apart and start rebuilding it.

Why this is not a hormone story

It is worth being precise about the estrogen part, because women reasonably worry about anything touching hormones.

Shilajit is not a hormone and does not add estrogen to your body. After menopause the estrogen signal that keeps the collagen framework and the mineral both being rebuilt goes quiet. Shilajit supports the body's own estrogen signaling and shifts the breakdown to build ratio, working with your own machinery rather than replacing a hormone. That is why it can sit alongside the rest of a woman's routine, including the calcium and vitamin D she is already taking.

The mechanism underneath, labeled honestly

A human result is strongest when the earlier stage work agrees. In cell research Kangari and colleagues in 2022 found shilajit accelerated the maturation of human stem cells into bone building cells, and Abbasi and colleagues in 2019 found a low dose raised osteoblast proliferation. In ovariectomized rats, shilajit improved density and lowered turnover markers. The collagen-gene findings are human but measured in muscle and skin tissue, so they show shilajit prompting collagen building generally, which the bone trial then confirms on bone density itself.

Safety and purity

The bone trial safety read was clean, with all labs normal and no dropouts for side effects, and across every human shilajit study, zero serious adverse events have been reported.

Optimum shilajit is from the Altai mountains, cold pressed and purified, independent third party lab tested, heavy metal free, and Prop 65 compliant in California. We are a small, family owned company out of Florida, and it comes as a box of tablets.

What this means for you

Keep taking your calcium. It supplies real material bone needs. Just understand that on its own it feeds one part of a three-part structure. Bone strength is the mineral, the collagen framework, and the signal to keep rebuilding all together, and after menopause all three fade at once. Shilajit is one of the few things that reaches all three, and in the human trial run on women in your position, the density moved the right way.

References

1. Pingali U, Nutalapati C. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial. Phytomedicine. 2022;105:154334. https://pubmed.ncbi.nlm.nih.gov/35933897/
2. Das A, et al. Skeletal muscle transcriptome response to shilajit supplementation (collagen and ECM gene cluster). 2016. https://pubmed.ncbi.nlm.nih.gov/27414521/
3. Das A, et al. The human skin transcriptome and microcirculation response to shilajit supplementation in healthy women. 2019. https://pubmed.ncbi.nlm.nih.gov/31161927/
4. Kangari P, et al. Shilajit accelerates osteogenic differentiation of human adipose-derived stem cells. 2022. https://pubmed.ncbi.nlm.nih.gov/36153551/
5. Abbasi A, et al. Effect of mumie on proliferation of osteoblast-like cells. 2019. https://pubmed.ncbi.nlm.nih.gov/31983854/
6. Sadeghi SMH, et al. "The effect of momiai (shilajit) on fracture healing: a randomized, double-blind, placebo-controlled clinical trial." 2020. n=160; healing time about 129 days vs 153 days on placebo. PMID 32310691. (Paywalled, URL cited.)